STT Form 144 Notice: 1,576 Vested Shares Listed for Sale on NYSE
Rhea-AI Filing Summary
State Street Corporation filing a Form 144 notifies a proposed sale of 1,576 common shares through Fidelity Brokerage Services on the NYSE, with an aggregate market value of $175,058.61 and approximately 283,695,342 shares outstanding. The shares were acquired via restricted stock vesting on 02/15/2025 (517 shares), 05/15/2025 (529 shares), and 08/15/2025 (530 shares), with payment characterized as compensation. The filing reports no sales by the person in the past three months and includes the standard signature/representation language certifying no undisclosed material adverse information.
Positive
- Securities arose from compensation vesting, indicating routine employee/shareholder alignment rather than an extraordinary transfer
- No sales reported in prior three months, suggesting this is not part of a pattern of frequent disposals
Negative
- None.
Insights
TL;DR Small proposed sale of vested restricted shares; unlikely to be market-moving given size relative to float.
This Form 144 discloses a notice to sell 1,576 vested common shares totaling $175,058.61. Relative to the reported ~283.7 million shares outstanding the position is immaterial, suggesting limited market impact. The acquisition dates indicate these were compensation-related restricted stock vestings across three dates in 2025. Absence of sales in the prior three months reduces evidence of ongoing disposal activity. The filing contains routine representations required by Rule 144 and does not include additional context such as officer/director status or trading plan adoption.
TL;DR Routine insider sale notice tied to vested compensation; governance implications minimal without role disclosure.
The notice reports sale through a brokerage and indicates the securities arose from restricted stock vesting and were paid as compensation. From a governance perspective, this is a standard disclosure. Material governance concerns would require information not present in the filing, such as the filer’s officer/director status or whether a Rule 10b5-1 plan governs the sale. The filing’s statement that no undisclosed material adverse information is known is standard language and not an independent confirmation of company conditions.